BRIEF-Bristol-Myers Squibb's Opdivo gets breakthrough therapy approval from FDA
June 27, 2016 at 07:11 AM EDT
* Bristol Myers Squibb Co - intends to file marketing application with health authorities based on results from phase 2 study ca209-275, other data